ACLU Calls on DEA To Allow Sale of Med Marijuana

function share_this(num) {
 tit=encodeURIComponent('ACLU Calls on DEA To Allow Sale of Med Marijuana');
 site = new Array(5);
 return false;

  ACLU Calls on DEA To Allow Sale of Med Marijuana

Posted by CN Staff on March 10, 2011 at 06:23:32 PT
By Stephen C. Webster  
Source: AlterNet 

USA -- The American Civil Liberties Union (ACLU) does not commonly take an active role in matters pertaining to the drug war, but in the case of Dr. Lyle E. Craker, a professor at the University of Massachusetts, outspoken is certainly one way to describe their position.Craker's name might sound familiar to keen observers of the drug war. After a decade of waging a hard-fought battle with the U.S. Drug Enforcement Agency (DEA), which repeatedly denied his application for the production of medical marijuana, he recently said he would call it quits, resigning his fight in bitter defeat.
The last DEA ruling against him came in January 2009, and contradicted the recommendation of DEA Administrative Law Judge Mary Ellen Bittner. His appeal of that decision languished for so long that last week, he and attorneys with the ACLU decided to drop the case."I'm disappointed in our system," the 70-year-old professor told the Associated Press last week. "But I'm not disappointed at what we did. I think our efforts have brought the problem to the public eye more. ... This is just the first battle in a war."On Monday evening, the ACLU released its final brief on Craker's case, which calls on the DEA to grant research permits for the production of medical cannabis. They also flatly state that cannabis medicines have not yet cleared the Food and Drug Administration (FDA) is because of the DEA's pernicious politics and tight monopoly on the granting of production licenses."The federal government’s official policy is that marijuana has no medical benefit," they noted. "But the government is unwilling to put its policy to the test of science: instead, the government exercises monopoly control over the nation’s supply of marijuana that may be used for scientific purposes, by allowing an agency whose mission is to explore the consequences of the abuse of marijuana—the National Institute on Drug Abuse (NIDA)—to determine what research may go forward regarding marijuana’s beneficial medical uses. The result is that [...] marijuana alone out of all potential medicines is subject to a special and obstructive process that places politics over science."Currently, the DEA has the marijuana plant as a "Schedule I" drug: a classification reserved for street drugs like heroin with no real medicinal value. However, the agency recently reclassified the psychoactive ingredient in marijuana, the chemical compound THC, to "Schedule III," thereby allowing pharmaceutical companies to begin producing cannabis-based drugs.The move was criticized by the National Organization for the Reform of Marijuana Laws (NORML) as the height of hypocrisy. The group suggested the DEA was merely legalizing marijuana for big business to repackage and resell at exorbitant prices, while keeping penalties in place for anyone who grows the plant itself.Thanks to the reclassification of the drug and not the plant, major pharmaceutical companies will soon be able to purchase synthesized THC from a government-licensed producer. Research on the drug's source, however -- the actual cannabis plant -- remains forbidden.And therein lies the problem, Craker's attorneys at the ACLU wrote."NIDA’s monopoly, created by DEA’s refusal to license any additional bulk manufacturer, has resulted in a dearth of privately-funded medical marijuana research for over 40 years. Until DEA ends the NIDA monopoly by registering another bulk manufacturer, such as Dr. Craker, to produce marijuana for privately-funded researchers, there cannot be an adequate and uninterrupted supply of marijuana for research intended to obtain FDA approval of marijuana as a prescription medicine."As a candidate for the U.S. Senate, President Barack Obama said he was in favor of eliminating the most stringent criminal penalties for marijuana possession, but has maintained that he does not support outright legalization.In a recent interview, the director of the Office on National Drug Control Policy said that prescription pills are by far the nation's largest drug problem, and warned that if marijuana were legal, more people might use it.Currently, 15 states and the District of Colombia allow marijuana to be prescribed as medicine.The ACLU's full brief was available online (PDF).URL:  Source: AlterNet (US)Author:  Stephen C. Webster Published: March 9, 2011Copyright: 2010 Independent Media InstituteContact: letters Website: Medical Marijuana Archives

Home    Comment    Email    Register    Recent Comments    Help    


Comment #7 posted by herbdoc215 on March 11, 2011 at 12:09:47 PT

I concur 100% with you and believe a lot of these 'labs' are going to have to comply with some kind of standards or they are subject to "Wizard of Oz" effect as I call it and very subject to marketing and manipulation as it really is all relative :) Peace, Steve
[ Post Comment ]


Comment #6 posted by josephlacerenza on March 11, 2011 at 05:52:18 PT

I agree that reporting THCA would be a "total potential THC" level. The other lab wants to say that by reporting the decarboxylated values I am not as "accurate". I made the arguement, that reporting THC alows a patient to know the "activity" of their cannabis not the "potential" activity.Reporting THCA vs THC would be beneficial for medibles, edibles, anything that has to be decarboxylated to be active. I have found only one way to test if there is a good cure on the bud, and that is to smoke it.If I used CBN, or the decarboxylation rate of THCA to THC as an indicator of "age", those reporters could be manipulated in the process of "curing". Improperly drying and storing of cannabis can cause the degradation of cannabinoid acids, falsy making it looked "cured" Certain flavonoids could be examined perhaps. 
Peer Reviewed Paper on Methods
[ Post Comment ]


Comment #5 posted by herbdoc215 on March 10, 2011 at 10:01:45 PT

Sorry it should say 'backed up' not back
Computers and cannabis smoke don't go well together as eventually it gets into keys and makes sticky...I've even gotten free keyboards from repair guy saying he would swap for all the hash he cleaned out of my laptop :) Peace, Steve
[ Post Comment ]


Comment #4 posted by herbdoc215 on March 10, 2011 at 09:55:20 PT

THCa may show potential, and also give baseline
as well as showing how much the batch was cured in contrast to others but only THC and other decarboxylated cannabinoids will show actual active ingredients. Personally I prefer GC/MS back up with gel electrophoresis myself as the gold standard? Peace, Steve Tuck  
[ Post Comment ]


Comment #3 posted by FoM on March 10, 2011 at 07:51:49 PT

Bill on MMJ Passes Illinois Committee Vote
March 10, 2011URL:
[ Post Comment ]


Comment #2 posted by FoM on March 10, 2011 at 07:50:09 PT

I can't respond since I don't understand. 
[ Post Comment ]


Comment #1 posted by josephlacerenza on March 10, 2011 at 07:00:57 PT:

THC vs THCA Reporting as TRUE Potency
I was hoping to get a discussion started on which is more accurate, representative, of cannabinoid activity in cannabis marijuana, hemp. GC/MS or HPLC?I have been in a discussion with one of the other labs in town. He thinks THCA, I think THC is more accurate at representing the activity of your medicine. The decarboxylated cannabinoids are the active ones!!!What do you guys think? Here is a link to some PEER reviewed papers from the NIDA and the UNODC... Tell me what you think: montanabiotech or leave a message on:
[ Post Comment ]

  Post Comment